Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries

Vaccine-product innovations that address barriers to immunization are urgently needed to achieve equitable vaccine coverage, as articulated in the new Immunization Agenda 2030 and the Gavi 5.0 strategy. In 2020, the Vaccine Innovation Prioritisation Strategy (VIPS) prioritized three innovations, nam...

Descripción completa

Detalles Bibliográficos
Autores principales: Giersing, Birgitte, Shah, Natasha, Kristensen, Debra, Amorij, Jean-Pierre, Kahn, Anna-Lea, Gandrup-Marino, Kristoffer, Jarrahian, Courtney, Zehrung, Darin, Menozzi-Arnaud, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657812/
https://www.ncbi.nlm.nih.gov/pubmed/34627624
http://dx.doi.org/10.1016/j.vaccine.2021.07.091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657812/
https://www.ncbi.nlm.nih.gov/pubmed/34627624
http://dx.doi.org/10.1016/j.vaccine.2021.07.091

Ejemplares similares